Financials
- Market Capitalization 2.35 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
74.81
Relación precio/flujo de caja
5.66
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1880 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.98 USD | +1.19% | -4.29% | +35.74% | +105.00% | 2.38 B USD | ||
| 1884 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 39.92 USD | -1.55% | -8.78% | +24.83% | -8.00% | 2.37 B USD | ||
| 1901 | NKTR Nektar Therapeutics - Common Stock | 67.17 USD | -1.68% | -9.23% | +10.19% | -8.33% | 2.27 B USD | ||
| 1906 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 27.28 USD | -1.12% | -9.16% | +13.76% | -32.43% | 2.25 B USD |